Tuesday, October 15, 2013

Top Glove : Hurt by price discounting (CIMB)

Top Glove
Current RM6.15
Target RM6.44
Hurt by price discounting

 Core net profit represented 97% of our full-year forecast, in line with expectations, but only 93% of consensus. Although sales volume was stronger yoy, lower ASP due to high competition weighed on its net profit. We believe this issue will persist.

Given intensifying competition and the proposed Medi-Flex privatisation, we cut our FY14-15 core net profit and introduced FY16 forecasts. Our target price, based on a higher 17.2x P/E (10% premium over our revised market P/E of 15.9x) vs. 17.5x previously and rolled over to CY15, is reduced. We remain Neutral as we still expect it to post stable earnings given the higher contribution from nitrile, which will compensate for weak natural rubber glove demand. We prefer Kossan.


Hit by lower ASP
Top Glove registered strong double-digit sales volume growth of 18% yoy due to robust demand for nitrile gloves, offsetting the weak natural rubber glove sales volume. Full-year revenue was, however, flat at RM2.3bn as selling prices fell due to lower raw material costs (latex prices declined 22% yoy; nitrile prices fell 28% yoy) and lower natural rubber glove prices. Top Glove lowered natural rubber glove prices to keep customers from switching to nitrile gloves. To some extent, we believe the group also had to lower the average selling price of nitrile gloves amid intense competition in the nitrile glove space. Despite the flat topline growth, EBITDA grew 4.1% yoy, partly due to forex gains of RM15.5m vs. a gain of RM4.3m last year.

Greater operating efficiency from new production lines and higher contribution from nitrile gloves also led to the jump in EBITDA. PBT, however, declined 1% due to higher depreciation cost and an associate loss from Icon Property. Given this, coupled with the higher effective tax rate in FY13, core net profit dropped 6.4% yoy.

Intensifying competition
We believe Top Glove will continue to experience pricing pressure as competition intensifies due to the influx of new capacities to the industry. The strong demand for nitrile gloves also does not augur well for Top Glove.

Proposal to privatise 79.77%-owned Medi-Flex
In a separate announcement, Top Glove said that its wholly-owned subsidiary, Top Glove Sdn Bhd (TGSB), has proposed to privatise its 79.77%-owned SGX-listed subsidiary, Medi-Flex Limited. This was unexpected as the management had been busy combating its declining natural rubber glove sales. Performance of this subsidiary was also not impressive prior to FY13. TGSB is extending an offer price of S$0.15 (RM0.38) per share, which represents a 15% premium over Medi-Flex’s last closing price of S$o.13. The offer price translates into an FY13 P/E of 14.5x, based on the subsidiary's FY13 net profit of RM24.7m. It will cost TGSB RM71m to acquire the remaining 20.2% stake that it does not own. TGSB will satisfy this using its internally-generated funds.

Briefly on Medi-Flex
Medi-Flex is a natural rubber and nitrile glove manufacturer. In its latest financial FY13 results, which were released last Friday, revenue increased 19% yoy while net profit jumped 134% yoy. The strong results were mainly due to capacity additions from new production lines, an increase in the sales of nitrile and cleanroom gloves as well as improved manufacturing efficiency. Nitrile and cleanroom gloves command a higher margin.

Privatisation of Medi-Flex enhances long-term earnings
Our post-results FY14-16 net profit forecasts are further reduced by 2-4% after consolidating the remaining 20% of Medi-Flex’s earnings and factoring in lower interest income. While the privatisation is earnings-dilutive in the near term, we are positive on this exercise as Medi-Flex should continue to grow strongly given its focus on manufacturing nitrile gloves. This will, in turn, boost Top Glove’s bottomline in the longer term.



Source/Extract/Excerpts/来源/转贴/摘录: CIMB-Research,
Publish date:14/10/13

No comments:

Post a Comment

Warren E. Buffett(沃伦•巴菲特)
Be fearful when others are greedy, and be greedy when others are fearful
别人贪婪时我恐惧, 别人恐惧时我贪婪
投资只需学好两门课: 一,是如何给企业估值,二,是如何看待股市波动
吉姆·罗杰斯(Jim Rogers)
“错过时机”胜于“搞错对象”:不会全军覆没!”
做自己熟悉的事,等到发现大好机会才投钱下去

乔治·索罗斯(George Soros)

“犯错误并没有什么好羞耻的,只有知错不改才是耻辱。”

如果操作过量,即使对市场判断正确,仍会一败涂地。

李驰(中国巴菲特)
高估期间, 卖对, 不卖也对, 买是错的。
低估期间, 买对, 不买也是对, 卖是错的。

Tan Teng Boo


There’s no such thing as defensive stocks.Every stock can be defensive depending on what price you pay for it and what value you get,
冷眼(冯时能)投资概念
“买股票就是买公司的股份,买股份就是与陌生人合股做生意”。
合股做生意,则公司股份的业绩高于一切,而股票的价值决定于盈利。
价值是本,价格是末,故公司比股市重要百倍。
曹仁超-香港股神/港股明灯
1.有智慧,不如趁势
2.止损不止盈
成功者所以成功,是因为不怕失败!失败者所以失败,是失败后不再尝试!
曾淵滄-散户明灯
每逢灾难就是机会,而是在灾难发生时贱价买股票,然后放在一边,耐性地等灾难结束
  • Selected Indexes 52 week range

  • Margin of Safety

    Investment Clock

    World's First Interactive Investment Clock